Janney Montgomery Scott LLC - NOVARTIS A G ownership

NOVARTIS A G's ticker is NVS and the CUSIP is 66987V109. A total of 1,136 filers reported holding NOVARTIS A G in Q1 2019. The put-call ratio across all filers is 0.60 and the average weighting 0.4%.

Quarter-by-quarter ownership
Janney Montgomery Scott LLC ownership history of NOVARTIS A G
ValueSharesWeighting
Q2 2024$26,499
+8.4%
248,911
-1.5%
0.08%
+11.0%
Q1 2024$24,450
-6.7%
252,761
-2.6%
0.07%
-14.1%
Q4 2023$26,207
-3.6%
259,556
-2.8%
0.08%
-15.8%
Q3 2023$27,187
-3.0%
266,901
-4.0%
0.10%
+3.1%
Q2 2023$28,042
+11.7%
277,896
+1.8%
0.10%
-4.9%
Q1 2023$25,113
-9.3%
272,968
-10.6%
0.10%
-4.6%
Q4 2022$27,698
-99.9%
305,309
+1.9%
0.11%
+10.2%
Q3 2022$22,776,000
-8.5%
299,636
+1.6%
0.10%
-12.5%
Q2 2022$24,885,000
-3.1%
294,796
+0.8%
0.11%
+1.8%
Q1 2022$25,672,000
+19.5%
292,561
+19.1%
0.11%
+32.5%
Q4 2021$21,484,000
+6.3%
245,615
-0.6%
0.08%
-3.5%
Q3 2021$20,218,000
-6.8%
247,214
+3.9%
0.09%
-10.4%
Q2 2021$21,699,000
+10.0%
237,825
+3.1%
0.10%0.0%
Q1 2021$19,718,000
-10.1%
230,675
-0.7%
0.10%
-9.4%
Q4 2020$21,926,000
+4.8%
232,194
-3.5%
0.11%
-10.9%
Q3 2020$20,925,000
-2.4%
240,627
-2.0%
0.12%
-11.9%
Q2 2020$21,437,000
+2.0%
245,439
-3.7%
0.14%
-18.7%
Q1 2020$21,009,000
-13.8%
254,804
-1.0%
0.17%
+3.8%
Q4 2019$24,369,000
+13.0%
257,354
+3.7%
0.16%
+1.9%
Q3 2019$21,573,000
-2.7%
248,251
+2.2%
0.16%
-7.6%
Q2 2019$22,173,000
+0.4%
242,828
+5.7%
0.17%
-6.6%
Q1 2019$22,087,000
+19.3%
229,740
+6.5%
0.18%
+2.2%
Q4 2018$18,513,000
+2.2%
215,746
+2.7%
0.18%
+14.1%
Q3 2018$18,106,000
+29.2%
210,141
+13.3%
0.16%
+15.6%
Q2 2018$14,015,000
-7.2%
185,530
-0.6%
0.14%
-11.2%
Q1 2018$15,096,000
+1.6%
186,710
+5.5%
0.15%
-1.3%
Q4 2017$14,857,000
+5.2%
176,953
+7.5%
0.15%
-4.3%
Q3 2017$14,127,000
+8.6%
164,549
+5.6%
0.16%
-0.6%
Q2 2017$13,007,000
+10.8%
155,829
-1.4%
0.16%
+3.8%
Q1 2017$11,737,000
+23.8%
158,029
+21.4%
0.16%
+9.1%
Q4 2016$9,478,000
+74.8%
130,119
+89.5%
0.14%
+49.0%
Q3 2016$5,423,000
+30.0%
68,682
+19.2%
0.10%
-11.9%
Q1 2016$4,173,000
-33.6%
57,603
-21.1%
0.11%
-32.7%
Q4 2015$6,280,000
-15.0%
72,993
-9.1%
0.16%
-22.1%
Q3 2015$7,384,000
-99.9%
80,335
+8.4%
0.21%
+35.9%
Q2 2015$7,288,955,000
+106044.7%
74,120
+6.4%
0.15%
+19.5%
Q1 2015$6,867,000
-99.9%
69,634
+6.8%
0.13%
+5.8%
Q4 2014$6,039,601,000
+4.7%
65,180
+6.4%
0.12%
+0.8%
Q3 2014$5,768,591,000
+17.4%
61,283
+12.9%
0.12%
+12.1%
Q2 2014$4,912,070,000
+37.5%
54,259
+29.2%
0.11%
+24.4%
Q1 2014$3,571,882,000
+10.0%
42,012
+4.0%
0.09%0.0%
Q4 2013$3,246,564,000
-7.7%
40,390
-11.9%
0.09%
-18.9%
Q3 2013$3,517,622,000
+534.4%
45,856
+484.7%
0.11%
+82.8%
Q2 2013$554,503,0007,8420.06%
Other shareholders
NOVARTIS A G shareholders Q1 2019
NameSharesValueWeighting ↓
Martin Investment Management, LLC 318,637$27,960,0007.08%
MANAGED ASSET PORTFOLIOS, LLC 417,183$36,608,0005.02%
SAL Trading, LLC 233,600$20,498,0004.77%
SCHARF INVESTMENTS, LLC 1,340,680$117,662,0003.49%
SAL Trading, LLC 155,783$13,670,0003.18%
First Fiduciary Investment Counsel, Inc. 169,371$14,862,0002.90%
PRENTISS SMITH & CO INC 55,026$4,829,0002.90%
GARLAND CAPITAL MANAGEMENT INC 47,630$4,180,0002.77%
Cullen Capital Management, LLC 3,295,271$289,160,0002.66%
WILKINS INVESTMENT COUNSEL INC 133,880$11,748,0002.65%
View complete list of NOVARTIS A G shareholders